Pilot and Feasibility Program in Urology (R21)

The summary for the Pilot and Feasibility Program in Urology (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pilot and Feasibility Program in Urology (R21): The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) , the Division of Cancer Biology of the National Cancer Institute (NCI), and the Reproductive Sciences Branch of the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) invite Exploratory/Developmental grant applications from investigators with research interests in urology and that serve the mission of NIH. The primary intent of this initiative is to foster the development of high-risk pilot and feasibility research by newly independent or established investigators developing a new line of research. Information thus obtained would allow subsequent submission of R01 applications focusing on research problems relevant to the study of urologic diseases and their complications. These grants are not intended to support or supplement ongoing funded research of an established investigator, or to serve as an alternative mechanism of support for projects not receiving funding as competing continuation applications.
Federal Grant Title: Pilot and Feasibility Program in Urology (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Income Security and Social Services Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-156
Type of Funding: Grant
CFDA Numbers: 93.39393.396
CFDA Descriptions: Cancer Cause and Prevention Research 93.396 Cancer Biology Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 02, 2006
Creation Date: Nov 09, 2006
Archive Date: Dec 15, 2006
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.849 -- Kidney Diseases, Urology and Hematology Research
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Special district governments County governments Native American tribal governments (Federally recognized) City or township governments Independent school districts State governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional...
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Opti...
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not...
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not...
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com